American Depositary Receipt. Agora, Inc. is a foreign issuer that files on a foreign accounting basis, so its per-share figures and ratios are not directly comparable to US-listed companies. Invest Viable does not provide an Investment Score for ADRs, and reports cannot be built on them. You can still use the Valuator to run your own valuation.
NASDAQ
API
Last Price
US $3.17
Updated
November 20, 2026
LAST PRICE
$3.17
Nov 20, 2026 · Close
Profit margin
6.77%
Profit margin
Current Ratio
4.6:1
Current Ratio
D/E: 0.19
Capital Returns
2.02%
Return on equity
ROIC: -0.91%
Valuation History
24.4X
Price to Earnings
EV/EBITDA: 24.5X
Cash flow
27M
Annual operating cash flow
Profit margin
6.77%
Profit margin
KEY FIGURES
MKT CAP
$296.4M
EPS
TTM$0.13
EPS Growth (1Y)
-121.04%
PEG
TTM-
P/E
TTM23.71x
P/S
TTM1.69x
YIELD
-
GROWTH (5Y CAGR)
Revenue
1.10%
EBITDA
-
Cash flow
6.17%
Base Cash Flow Valuation (DCF)
Fair Value
Market $3.17
—
Default assumptions
Base EBITDA Valuation
Fair Value
Market $3.17
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.
Overall, Agora, Inc. scores 48 out of 100, indicating Moderate fundamentals.
Valuation
Agora, Inc. shows a mixed valuation profile — some metrics indicate reasonable pricing while others suggest the stock trades above fundamental value. Review the valuation checks (#1–#8) to identify which metrics look favorable and which are less so.
Financial Strength
The balance sheet is generally sound, with most financial strength checks passing. One or two areas fall short of the strongest thresholds but do not indicate distress. Review the financial checks (#9–#16) for specifics.
Business Performance
Most performance checks have failed, indicating significant operational weakness across growth, profitability, and capital efficiency. Review the performance checks (#17–#28) for the full picture.
Solid finances and low valuation, but performance is weakening. The balance sheet is strong and the stock price is low, but the performance checks (#17–#28) show deteriorating operations. The question is whether the weakness is cyclical or structural.
Valuation
Financial
Performance